Insulin-like growth factor 1

From WikiMD's WELLNESSPEDIA

(Redirected from IGF-I)

A protein involved in growth and development


File:IGF-1.GIF
Diagram of IGF-1 structure

Insulin-like Growth Factor 1 (IGF-1) is a protein that in humans is encoded by the IGF1 gene. It is a hormone similar in molecular structure to insulin. IGF-1 plays an important role in childhood growth and continues to have anabolic effects in adults.

Structure[edit]

IGF-1 is a small protein with a molecular weight of approximately 7,649 daltons. It consists of 70 amino acids in a single chain with three intramolecular disulfide bridges. The structure of IGF-1 is similar to that of insulin, which is why it is referred to as "insulin-like."

Function[edit]

IGF-1 is primarily produced in the liver as an endocrine hormone and is also produced in target tissues in a paracrine/autocrine fashion. It is a major mediator of the effects of growth hormone (GH). Growth hormone is made in the pituitary gland, released into the bloodstream, and stimulates the liver to produce IGF-1. IGF-1 then stimulates systemic body growth and has growth-promoting effects on almost every cell in the body, especially skeletal muscle, cartilage, bone, liver, kidney, nerve, skin, and lung cells.

Mechanism of Action[edit]

IGF-1 exerts its effects by binding to the IGF-1 receptor (IGF1R), which is a receptor tyrosine kinase. Upon binding, IGF-1 activates the receptor, leading to the activation of intracellular signaling pathways such as the PI3K/AKT pathway and the MAPK/ERK pathway. These pathways promote cell growth, proliferation, and survival.

Clinical Significance[edit]

IGF-1 levels are important in the diagnosis and management of growth disorders. Low levels of IGF-1 can indicate growth hormone deficiency, while high levels can be associated with conditions such as acromegaly and gigantism. IGF-1 is also being studied for its potential role in aging, cancer, and metabolic disorders.

Therapeutic Use[edit]

Recombinant IGF-1 is used in the treatment of growth failure in children with severe primary IGF-1 deficiency or with growth hormone gene deletion who have developed neutralizing antibodies to growth hormone.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Insulin-like_growth_factor_1&oldid=6294783"